GLS and familial pancreatic carcinoma: Consistent with this finding, our study demonstrates the synergistic antiproliferative effect of combination treatment of 1E5 and GLS1 inhibitor BPTES, highlighting the importance of targeting multiple glutamine utilization nodes to overcome the limited efficacy of GLS1 inhibition alone in pancreatic cancer.